Support By : Li-lab
| PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
|---|---|---|---|---|---|
| Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | glipizide | 3478 | drug-path |
| p53 signaling pathway | R-HSA-168638 | map04115 | glipizide | 3478 | drug-path |
| Alzheimer's disease | R-HSA-1643685 | 0 | bromocriptine | 31101 | drug-path |
| Huntington's disease | R-HSA-1643685 | 0 | bromocriptine | 31101 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | bromocriptine | 31101 | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | bromocriptine | 31101 | drug-path |
| MAPK signaling pathway | R-HSA-9652817 | map04010 | bromocriptine | 31101 | drug-path |
| Parkinson's disease | R-HSA-1643685 | 0 | bromocriptine | 31101 | drug-path |
| Type II diabetes mellitus | R-HSA-2127377 | map04930 | bromocriptine | 31101 | drug-path |
| Renal cell carcinoma | R-HSA-9794523 | map05211 | bromocriptine | 31101 | drug-path |
| Natural killer cell mediated cytotoxicity | R-HSA-5218921 | map04650 | bromocriptine | 31101 | drug-path |
| B cell receptor signaling pathway | R-HSA-983705 | map04662 | bromocriptine | 31101 | drug-path |
| Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | bromocriptine | 31101 | drug-path |
| Insulin signaling pathway | R-HSA-74752 | map04910 | bromocriptine | 31101 | drug-path |
| Apoptosis | R-HSA-109581 | map04210 | bromocriptine | 31101 | drug-path |
| TGF-beta signaling pathway | R-HSA-168638 | map04350 | bromocriptine | 31101 | drug-path |
| Colorectal cancer | R-HSA-4791275 | map05210 | bromocriptine | 31101 | drug-path |
| Renal cell carcinoma | R-HSA-9794523 | map05211 | cotinine | 5337997 | drug-path |
| Natural killer cell mediated cytotoxicity | R-HSA-5218921 | map04650 | cotinine | 5337997 | drug-path |
| Adherens junction | R-HSA-451386 | map04520 | cotinine | 5337997 | drug-path |